The new Cochlear™ Nucleus® Nexa™ System is the first and only hearing implant featuring internal memory and upgradeable ...

Macquarie has released a new note on Cochlear Ltd (ASX: COH) shares following the company's FY25 profit guidance change.

Slower-than-expected sales growth over the past few months has led hearing implants giant Cochlear to cut its FY25 underlying ...

Cochlear cites ongoing weakness in its service (sound processor) division as the key reason behind its full-year earnings ...

Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782. The content is current as ...

Cochlear could be an ASX share to buy and hold for growth investors. It is the global leader in implantable hearing solutions ...

ASX health stocks rise in week ending June 13, 2025 as Cochlear downgrades full-year profit expectations but launches a world ...

Investors haven't responded positively to this update. Let's dig deeper into it. The post Cochlear shares sink 9% on guidance ...

Cochlear shares were trading higher on Thursday morning after initially sinking at market open on the back of the hearing ...

Mayne Pharma (ASX:MYX) shareholders have overwhelmingly approved the company’s $600 million takeover scheme of arrangement, ...